Patent details

Basic Information

Publication number:

EP1382339

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP030243323

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compositions containing pyrrolo ê2,3-d pyrimidine derivatives

French Title of Invention:

Compositions contenant des dérivés de pyrroloê2,3-d pyrimidine

German Title of Invention:

Pyrroloê2,3-d pyrimidinderivate enthaltende Zusammensetzungen

SPC Number:

Dates

Filing date:

23/11/2000

Grant date:

05/12/2007

EP Publication Date:

05/12/2007

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/01/2004

EP B1 Publication Date:

05/12/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

23/11/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/11/2000

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, CT 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

05/12/2007

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Munchhof Michael John

Address:

United States (US)

2

Name:

Blumenkopf Todd Andrew

Address:

United States (US)

3

Name:

Flanagan Mark Edward

Address:

United States (US)

Priority

Priority Number:

170179 P

Priority Date:

10/12/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/519;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

18/09/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages